{
    "clinical_study": {
        "@rank": "107578", 
        "acronym": "CILOVE", 
        "arm_group": {
            "arm_group_label": "laparoscopic management", 
            "arm_group_type": "Experimental", 
            "description": "Tumor Debulking Surgery by laparoscopy"
        }, 
        "brief_summary": {
            "textblock": "This prospective nonrandomized multicenter phase II study, will evaluate the possibility of\n      performing a laparoscopic interval debulking  after a minimum of 3 cycles of chemotherapy in\n      highly chemo-sensitive patients with advanced ovarian, tubal cancer or primary peritoneal."
        }, 
        "brief_title": "Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ovarian Cancer", 
            "Fallopian Tube Cancer", 
            "Peritoneal Cavity Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Peritoneal Neoplasms", 
                "Fallopian Tube Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > or = 18 years\n\n          -  performance status WHO < 2\n\n          -  Epithelial ovarian, fallopian tubes or primary peritoneal carcinoma (histologically\n             confirmed)\n\n          -  Unresectable disease because of FIGO stage IV disease proven by imaging (CT Scan or\n             PET CT) and/or diffuse extensive carcinosis considered unresectable for advanced FIGO\n             stage IIIc; or patients unable to support a radical primary surgery because of age,\n             comorbidities or altered general condition.\n\n          -  No previous debulking surgery before neoadjuvant chemotherapy.\n\n          -  Patients treated with a minimum of 3 cycles of platinum-based neoadjuvant\n             chemotherapy.\n\n          -  Response to chemotherapy was radiologically confirmed (Scan-TAP) prior to interval\n             surgery:\n\n        No evidence of peritoneal supra-mesocolic carcinomatosis ; Residual pelvic masses smaller\n        than 10 cm ; Absence of suspect supra-centimeter retroperitoneal lymphadenopathy\n\n          -  able to read, write and understand French.\n\n          -  Member of a Social Security scheme.\n\n          -  written informed consent.\n\n        Exclusion Criteria:\n\n          -  Patient unable to support laparoscopy\n\n          -  psychiatric condition or social or geographic situation that would impede appropriate\n             study participation\n\n          -  Concomitant participation in another clinical trial evaluating surgical treatment\n             (interfering with the evaluation of the main endpoint)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "47", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01905163", 
            "org_study_id": "2012-A01391-42"
        }, 
        "intervention": {
            "arm_group_label": "laparoscopic management", 
            "intervention_name": "Tumor Debulking Surgery by laparoscopy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Laparoscopy, interval debulking surgery", 
        "lastchanged_date": "April 23, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Christophe Pomel, Pr", 
                    "phone": "33473278121"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63011"
                    }, 
                    "name": "Centre Jean Perrin"
                }, 
                "investigator": {
                    "last_name": "Christophe Pomel, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michel Canis, Pr"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "CHU Estaing"
                }, 
                "investigator": {
                    "last_name": "Michel Canis, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Elisabeth CHEREAU EWALD, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13009"
                    }, 
                    "name": "Institut Paoli Calmettes"
                }, 
                "investigator": {
                    "last_name": "Elisabeth CHEREAU EWALD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Virginie FOURCHOTTE, Dr"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75005"
                    }, 
                    "name": "Institut Curie"
                }, 
                "investigator": {
                    "last_name": "Virginie Fourchotte, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabrice Lecuru, Pr"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75015"
                    }, 
                    "name": "H\u00f4pital Europ\u00e9en Georges-Pompidou"
                }, 
                "investigator": {
                    "last_name": "Fabrice Lecuru, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Roman ROUZIER, Pr"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Cloud", 
                        "country": "France", 
                        "zip": "92210"
                    }, 
                    "name": "Institut Curie - H\u00f4pital Ren\u00e9 Huguenin"
                }, 
                "investigator": {
                    "last_name": "Roman ROUZIER, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Arnaud WATTIEZ, Pr"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67000"
                    }, 
                    "name": "H\u00f4pital de Hautepierre"
                }, 
                "investigator": {
                    "last_name": "Arnaud Wattiez, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gw\u00e9na\u00ebl FERRON, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31052"
                    }, 
                    "name": "Institut Claudius Regaud"
                }, 
                "investigator": {
                    "last_name": "Gw\u00e9na\u00ebl FERRON, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Prospective Study Assessing the Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinomatosis of Ovarian Origin, Tubal or Primary Peritoneal, in Chemosensitive Patients Treated by Neoadjuvant Chemotherapy.", 
        "overall_contact": {
            "email": "emilie.thivat@cjp.fr", 
            "last_name": "Emilie THIVAT, PhD", 
            "phone": "33473278089"
        }, 
        "overall_official": {
            "affiliation": "Centre Jean Perrin", 
            "last_name": "Christophe POMEL, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: ANSM - Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Feasibility of the surgical laparoscopic management of interval debulking surgery will be assessed by the rate of conversion to laparotomy.", 
            "measure": "the rate of conversion to laparotomy", 
            "safety_issue": "No", 
            "time_frame": "surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01905163"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Port site metastases", 
                "safety_issue": "No", 
                "time_frame": "during 1 year post surgery"
            }, 
            {
                "measure": "Morbidity: intraoperative and postoperative complications", 
                "safety_issue": "Yes", 
                "time_frame": "during surgery and 1 year post surgery"
            }, 
            {
                "measure": "Pain", 
                "safety_issue": "Yes", 
                "time_frame": "during the hospital stay (an expected average of 5 days), at 1 week, 1 month, 3 and 6 months post surgery"
            }, 
            {
                "measure": "Quality of life using EORTC QLQ-C30", 
                "safety_issue": "No", 
                "time_frame": "before surgery (an expected average of 7 days before surgery), 1 week , 1 month, 3 and 6 months post-surgery"
            }, 
            {
                "description": "economic evaluation will be assess by a quantification of the additional costs of surgery, duration and cost of hospitalization, number of possible re-interventions or hospitalizations.", 
                "measure": "Economic evaluation", 
                "safety_issue": "No", 
                "time_frame": "1 year post-surgery"
            }
        ], 
        "source": "Centre Jean Perrin", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Jean Perrin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}